Generics 2

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tenoxicam manufacturers

2 products found

Filters

Filters

Filters , active

Country of origin : Egypt

Clear all

2 products found

tenoxicam

Tablets, film coated 20mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
WHO
Manufacturer #16472
This pharmaceutical company, based in the Middle East, has been operating for over four decades. With a focus on production, they are a leading manufacturer in the region, particularly known for their antibiotics, lyophilized products, and spansule capsules. They hold significant market share in the local market and boast the number one spot in pharmaceutical product exports. They offer a wide range of prescription drugs, including those in solid, injectable, oral, and liquid forms. The company has obtained EU and US GMP approvals, indicating adherence to high manufacturing standards. Their production lines encompass various therapeutic areas, with key focuses on antibiotics, oncology, and cardiology. While no specific product patents were mentioned, their commitment to research and development suggests an ongoing effort to innovate and expand their offerings.

Manufacturer usually replies in 6 days

Want to see all 2 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Tenoxicam:

Tenoxicam, also known under the popular brand name Mobiflex, is a nonsteroidal anti-inflammatory medication used in the treatment of indications such as inflammation, swelling, stiffness, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and periarthritis of the shoulders or hips. It was originally patented by the pharmaceutical products manufacturing company Roche in 1974, following approval for medical sale on the marketplace in 1987.
Currently, it can be found for global sale and wholesale by many tenoxicam manufacturers and tenoxicam suppliers under other brand names including Tilatil, Tilcitin, and Alganex, along with other generic variations. This emerged genericness, driven by the expiration of the pharmaceutical products patent, has in large part accelerated its popularity. Making it both cost-effective and attractive for distributors to list for sale on the global marketplace. Where it can be found under numerous names and at various price points.

Method of action of tenoxicam:

Tenoxicam belongs to a group of medications termed nonsteroidal anti-inflammatory drugs, specifically it is within the oxicams class. This class binds closely to plasma proteins to carry out its effects. Although the exact mechanism of action for tenoxicam remains obscure, it is thought that it functions through the inhibition of cyclooxygenase by deactivation or irregulation of its underlying genes of COX-1 and COX-2. This subsequently causes peripheral inhibition of prostaglandin synthesis, which is necessary to sensitize pain receptors. Therefore, their inhibition accounts for the analgesic effects of tenoxicam. Additionally, antipyresis may occur through central action on the hypothalamus, resulting in peripheral dilation, increased blood flow, and heat loss.

Form and dosage of tenoxicam:

As with other drugs, the final form and packaging of tenoxicam is dependent on the manufacturers and suppliers, as well as the distributors and specific order. However, tenoxicam is typically listed for sale in different forms such as tablets, film-coated-tablets, solution for injection, and capsules. Tenoxicam is a prescription medication in most countries, such as the United Kingdom, but remains over the counter in others, such as the United States. Therefore, it is recommended that the local regulations be checked before attempting to acquire this product. Normal doses for the treatment of pain and inflammation in rheumatic disease and acute musculoskeletal disorders tend to be 20 mg once daily by mouth, or 20 mg once daily for 1–2 days through the intravenous injection or by intramuscular injection route. These values are however subject to change based on the manufacturers’ literature and professional medical advice.

Tenoxicam on Pipelinepharma:

Currently, we have found 9 trusted tenoxicam manufacturers and tenoxicam suppliers from our global list of online B2B wholesale sellers. These manufacturers and wholesale providers are located in various countries including the European Union, Egypt, Guatemala, and Bangladesh. Each company listed on our online B2B marketplace has been verified by the Pipelinepharma team according to strict quality control. This ensures the seriousness of each provider while reducing sourcing mileage, making for a hassle-free experience for all parties.

Price of tenoxicam and how to buy:

The cost of tenoxicam is highly dependent on numerous variables such as organisation, quantity, and market. Therefore, the price is subject to change, and an exact figure cannot be given. However, to aid in the sourcing process, manufacturers, suppliers, and distributors may choose to list their desired cost for their product on the online Pipelinepharma B2B marketplace. If indicated, an ‘Accept’ and ‘Negotiate’ button will appear next to the listing. In the absence of an indicated price, a ‘Get offer’ button will be displayed instead. This interface encourages a rapid transaction period, cutting down on overhead costs while increasing satisfaction for all parties.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible